With your own knowledge and the help of the following document:

Document 1 (Title: Parasitology and Management of Enterobius vermicularis Infection): Enterobius vermicularis (pinworm) infection represents a common helminthic condition with distinctive clinical and epidemiological characteristics requiring accurate understanding for appropriate diagnosis and management. The parasitic lifecycle demonstrates several notable features influencing clinical presentation and treatment approaches. Following ingestion of infective eggs, larval development progresses relatively rapidly through the gastrointestinal tract, with mature female worms typically beginning egg deposition within 4-6 weeks of initial infection rather than extended 3-month maturation periods documented with certain other helminthic species. Egg deposition occurs primarily through nocturnal migration of female worms to the perianal region, creating the characteristic pruritus ani that often prompts medical attention. Pulmonary involvement including Löffler's syndrome (transient pulmonary infiltrates with eosinophilia) represents a potential manifestation of certain tissue-migrating helminthic infections but characteristically does not occur during pinworm infection due to its non-migratory lifecycle confined to the intestinal lumen. Hematological assessment typically reveals minimal abnormalities, though mild eosinophilia (5-15%) may occasionally develop in some cases, particularly with heavy parasite burdens or prolonged infection. Diagnostic approaches focus on detection of characteristic eggs through adhesive tape preparations rather than direct visualization of adult worms, which remain predominantly within the intestinal lumen rather than being evacuated through the oral route, distinguishing this infection from certain other parasitic conditions where adult worm passage may occur. Treatment typically involves benzimidazole compounds including mebendazole and albendazole, with flubendazole representing an alternative therapeutic option in some geographical regions. Comprehensive management includes treating household contacts and environmental measures addressing potential fomite transmission through bedding and clothing.
Document 2 (Title: Urinary Obstruction and Stasis   Kidney): The pressure within the renal pelvis is normally close to zero. When this pressure increases because of obstruction or reflux, the pelvis and calyces dilate. The degree of hydronephrosis that develops depends on the duration, degree, and site of the obstruction (Figure 12–4). The higher the obstruction, the greater the effect on the kidney. If the renal pelvis is entirely intrarenal and the obstruction is at the ureteropelvic junction, all the pressure will be exerted on the parenchyma (Klein et al., 2010). If the renal pelvis is extrarenal, only part of the pressure produced by a ureteropelvic stenosis is exerted on the parenchyma; this is because the extrarenal pelvis is embedded in fat and dilates more readily, thus "decompressing" the hydronephrotic left renal pelvis. Low density mass (P) in the left renal sinus had an attenuation value similar to that of water, suggesting the correct diagnosis. Unless intravenous contrast material is used, differentiation from a peripelvic cyst may be difficult. In the earlier stages, the renal pelvic musculature undergoes compensatory hypertrophy in its effort to force urine past the obstruction. Later, however, the muscle becomes stretched and atonic and decompensated. The progression of hydronephrotic atrophy is as follows (Chevalier, 2010; Rodriguez, 2004): 1. The earliest changes in the development of hydronephrosis are seen in the calyces. The end of a normal calyx is concave because of the papilla that projects into it; with increased intrapelvic pressure, the fornices become blunt and rounded. With persistence of increased intrapelvic pressure, the papilla becomes flattened, then convex (clubbed) as a result of compression enhanced by ischemic atrophy (Figure 12–5). The parenchyma between the calyces is affected to a lesser extent. The changes in the renal parenchyma are due to (a) compression atrophy from increased intrapelvic pressure (more accentuated with intrarenal pelves) and (b) ischemic atrophy from hemodynamic changes, mainly manifested in arcuate vessels that run at the base of the pyramids parallel to the kidney outline and are more vulnerable to compression between the renal capsule and the centrally increasing intrapelvic pressure. 2. This spotty atrophy is caused by the nature of the blood supply of the kidney. The arterioles are end arteries; therefore, ischemia is most marked in the areas farthest from the interlobular arteries. As the back pressure increases, hydronephrosis progresses, with the cells nearest the main arteries exhibiting the greatest resistance. 3. This increased pressure is transmitted up the tubules. The tubules become dilated, and their cells atrophy from ischemia. It should be pointed out that a few instances of dilated renal pelves and calyces are not due to the presence of obstruction. Rarely, the renal cavities are congenitally capacious and thus simulate hydronephrosis. More commonly, hydronephrosis may occur in childhood owing to the back pressure associated with vesicoureteral reflux. If the valvular incompetence resolves (and this is common), some degree of the hydronephrotic changes may persist. These persisting changes may cause the physician to suspect the presence of obstruction, which may lead to unnecessary surgery. A radioisotope renogram to assess ureteral drainage function can be performed to determine whether organic obstruction is present. 4. Only in unilateral hydronephrosis are the advanced stages of hydronephrotic atrophy seen. Eventually, the kidney is completely destroyed and appears as a thin walled sac filled with clear fluid (water and electrolytes) or pus (Figure 12–6).
Document 3 (Title: Pharmacotherapy of Entamoeba histolytica Infections): Amebiasis management requires targeted pharmacological approaches addressing both intestinal and tissue infections through agents with distinctive spectrum and distribution characteristics. Therapeutic approaches typically distinguish between luminal agents effective against intestinal colonization versus tissue amebicides capable of treating invasive disease including hepatic abscesses. Nitroimidazole derivatives represent the cornerstone of tissue amebicide therapy due to their excellent distribution characteristics and direct amebicidal activity in hepatic and other extraintestinal sites. Metronidazole (FLAGYL®) demonstrates excellent tissue penetration and efficacy against invasive amebiasis, achieving therapeutic concentrations in hepatic abscess fluid and other invasive sites. Clinical studies document cure rates exceeding 90% for uncomplicated amebic liver abscess following appropriate metronidazole regimens. Similarly, secnidazole (FLAGENTYL®) provides effective treatment for tissue amebiasis with the advantage of single-dose administration due to its extended half-life compared to other nitroimidazoles. This pharmacokinetic advantage facilitates improved adherence in resource-limited settings while maintaining comparable clinical efficacy. Ornidazole (TIBÉRAL®) represents another effective tissue amebicide within the nitroimidazole class, demonstrating excellent penetration into hepatic tissue and abscess cavities with similar efficacy profiles to other class members. These agents contrast with medications primarily effective against intestinal luminal infection, including paramomycin and diloxanide furoate, which demonstrate poor systemic absorption limiting their utility against tissue invasion. Similarly, antifungal agents including econazole (PEVARYL®) lack amebicidal activity despite activity against certain other parasites, while antihelminthic agents such as flubendazole (FLUVERMAL®) demonstrate no meaningful activity against protozoan pathogens including Entamoeba histolytica. These pharmacological distinctions inform appropriate agent selection for amebiasis, typically requiring nitroimidazole derivatives for tissue invasion followed by luminal agents to prevent recurrence.

Answer the following list question.
Question: Select the incorrect statement(s) regarding oxyuriasis:
Options:
1. Löffler's syndrome manifests late in the course of oxyuriasis
2. The laying of eggs by female pinworms occurs 3 months after human infection
3. There may be moderate hypereosinophilia during oxyuriasis
4. The adult pinworm can be evacuated through the mouth
5. Flubendazole (FLUVERMAL®) is a medication used in oxyuriasis

Respond strictly in valid JSON format as shown below:
{"answer": ["1", "3"]} ← if options 1 and 3 are correct
Only output the JSON object. Do not include explanations, labels, markdown, or any other text.